(IN BRIEF) H. Lundbeck A/S has announced the initiation of CEO succession, with Deborah Dunsire choosing to retire from her role as President and CEO. Charl van Zyl has been appointed as the new President and CEO, and Dunsire will … Read the full press release
Posted in Business, Denmark, Healthcare, Management, Pharma & Biotech
Tagged appointment, biopharma, Board of Directors, CEO, Charl van Zyl, CNS, Deborah Dunsire, Eli Lilly, H. Lundbeck A/S, immunology, Lars Rasmussen, Lundbeck, Neurology, Novartis
13 new kits and assays allow for quantification of AAV viral titer and residual host cell DNA in cell and gene therapy Custom assay design provides dPCR users with access to tailored multiplex assays for use beyond biopharma applications Milestone … Read the full press release
Posted in Business, Germany, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged AAV, adeno-associated virus, biopharma, Cell and Gene Therapy, CGT, Dana Cipriano, digital PCR, DNA, dPCR, dPCR Assays, good manufacturing practice, imaging, QIAcuity, QIAGEN, qPCR, Residual DNA Quantification Kits, thermocycling, Thomas Schweins
13 nouveaux kits et tests permettent de quantifier le titre viral d’AAV et l’ADN résiduel de la cellule hôte en thérapie cellulaire et génique La conception de tests personnalisés permet aux utilisateurs de dPCR d’accéder à des tests multiplex personnalisés … Read the full press release
Posted in Business, Germany, Healthcare, Pharma & Biotech, Science, Technology
Tagged AAV, adeno-associated virus, biopharma, Cell and Gene Therapy, CGT, Dana Cipriano, digital PCR, DNA, dPCR, dPCR Assays, good manufacturing practice, imaging, QIAcuity, QIAGEN, qPCR, Residual DNA Quantification Kits, thermocycling, Thomas Schweins
13 neue Kits und Tests ermöglichen die Quantifizierung von AAV-Titern und restlicher Wirtszell-DNA in der Zell- und Gentherapie Custom Assay Design Service bietet Nutzern von dPCR Zugang zu maßgeschneiderten Multiplex-Assays über den Einsatz in Biopharma-Anwendungen hinaus Meilenstein mit mehr als … Read the full press release
Posted in Business, Germany, Healthcare, Investment, News, Pharma & Biotech, Science, Technology
Tagged AAV, adeno-associated virus, Adeno-assoziiertes Virus, Bildgebung, biopharma, Cell and Gene Therapy, CGT, Dana Cipriano, digital PCR, digitale PCR, DNA, dPCR, dPCR Assays, dPCR-Assays, good manufacturing practice, gute Herstellungspraxis, imaging, QIAcuity, QIAGEN, qPCR, Residual DNA Quantification Kits, Rest-DNA-Quantifizierungskits, thermocycling, Thomas Schweins, Zell- und Gentherapie
Expansion positions ILC as leading single use powder handling solutions provider to the global pharma & biopharma market FREDERICA, DE, USA, 01-Nov-2018 — /EuropaWire/ — ILC Dover, a global leader in flexible containment solutions for the pharmaceutical and biopharmaceutical industry … Read the full press release
Posted in Aviation & Aerospace, Business, Chemicals, Healthcare, Ireland, News, Pharma & Biotech, Security & Safety
Tagged biopharma, biopharmaceutical, Blarney, Brendan Lucey, containment solutions, County Cork, Curtis Gingles, expansion, flexible containment solutions, Fran DiNuzzo, ILC Dover, Ireland, pharma, Pharmaceutical, powder handling solutions
A plan taking place in almost 80 countries Subscription per five shares entitle the employee to one matching share[1] PARIS, 12-Jun-2018 — /EuropaWire/ — Sanofi launches today “Action 2018”, a worldwide stock purchase plan reserved for its employees. In doing such a … Read the full press release
Posted in France, Investment, Management, Pharma & Biotech
Tagged biopharma, Employees, health, Sanofi, shares, stock purchase plan, stock_purchase
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
